Completion of Clinical Trials for the TruCCOMS

Aortech International PLC 27 March 2000 Completion of Clinical Trials for the TruCCOMS AorTech International plc. ('AorTech') the Scottish-based manufacturer of cardiovascular devices, announces the successful completion of its patient clinical trials at the Papworth Hospital in the UK in respect of its Continuous Cardiac Output Monitoring System ('TruCCOMS'). Dr. Peter Duijst, AorTech's Medical Director said: 'I am delighted at the successful completion of this clinical trial. Clinical data from this study is presently being prepared for submission to the European Regulatory Authorities for CE Mark approval which we anticipate in the near future. This will enable AorTech to commence marketing the product in Europe. We have already received requests to use the product from several major hospitals in the United Kingdom, Germany and Italy which wish to utilize the TruCCOMS for their patients in surgery and intensive care because of its unique clinical benefits. 'The outstanding benefit of TruCCOMS is in its immediate response to cardiac output changes in patients. The medical community, who deal with critical and surgical care patients have been seeking a product which monitors patients cardiac output directly and also enables the physicians to recognise immediately any changes in cardiac output. Clinical evaluation of the new TruCCOMS system has demonstrated its unique performance and safety.' Bruno Lowinger, Vice President and responsible for the US said: 'The sales and marketing of TruCCOMS represents a major opportunity for AorTech in the US and we have already established two major clinical reference centres which have commenced use of the TruCCOMS product. There is continued interest from US hospitals in becoming clinical reference sites prior to our major product launch.' 27 March, 2000 Enquiries: AorTech International plc Eddie McDaid, Managing Director 01698 746 699 Bruno Lowinger, Vice President +1-734 827 2245 College Hill 0171 457 2020 Michael Padley / Nick Nelson For further information, visit AorTech's website at www.aortech.com Copies of this statement will be available for a period of 14 days from the Company's registered office: Phoenix Crescent, Strathclyde Business Park, Bellshill, Scotland ML4 3NU.